China Registry for Genetic / Metabolic Liver Diseases
CR-GMLD registry started on June 13, 2015 to collect cases of genetic/metabolic liver diseases from tertiary or secondary hospitals in mainland China. Demographics, diagnosis, laboratory test results, family history and prescriptions were recorded. Patients' whole blood and serum were collected for genetic testing and
| Condition(s) | Genetic/Metabolic Liver Diseases |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | CR-GMLD registry started on June 13, 2015 to collect cases of genetic/metabolic liver diseases from tertiary or secondary hospitals in mainland China. Demographics, diagnosis, laboratory test results, family history and prescriptions were recorded. Patients' whole blood and serum were collected for genetic testing and future researches. These patients will be followed-up every six to twelve months. |
| Who can participate | Inclusion Criteria: Patients who were diagnosed or possibly diagnosed with Wilson's disease, hereditary hemochromatosis, hereditary hyperbilirubinemias, inherited cholestatic liver disease or other genetic/metabolic liver diseases. Exclusion Criteria: Patients who are unable or unwilling to provide informed consent. |
| Sex | All |
| Lead sponsor | Beijing Friendship Hospital |
| Locations | Beijing, Beijing Municipality, China; Beijing, Beijing Municipality, China; Beijing, Beijing Municipality, China; Beijing, Beijing Municipality, China; Guangzhou, Guangdong, China; Shijiazhuang, Hebei, China (+6 more sites) |
| Start date | 2015-06-13 |
| NCT ID | NCT03131427 |
| Official listing | https://clinicaltrials.gov/study/NCT03131427 |